Proven leadership in Cardiovascular, Metabolic, Renal, Inflammatory, Dermatology, Wound Healing, Regenerative, and Orphan Diseases
Integrium is a full-service Clinical Proof of Concept (PoC) Firm focused within the therapeutic areas of Cardiovascular, Metabolic, Renal, Inflammatory, Dermatology, Wound Healing, Regenerative, and Orphan Diseases.
Although we have the scientific, medical, operational, and regulatory expertise to cover all stages of clinical development (Phase I-IV), we are Experts in the Strategy, Design and Execution of Clinical PoC Trials. This might be a single-site, or first-in-man study (when a procedure is tested on humans for the first time), all the way through to multi-national medical trials with many hundreds of sites and thousands of patients.
Integrium’s Client Base
Integrium’s client base is diverse, consisting of specialty, small, mid-size, and large companies, many of which we have worked with many times over. We have the flexibility and breadth to provide highly customized management services for anything from a multi-study program to functional-level support for an individual trial for biopharmaceutical company clients.
Integrium was founded in 1998 by clinical research thought leaders who had a vision of building a CRO based on therapeutic focus and excellence. These individuals continue to lead the company today and we are now truly international, with offices in North America and formal alliances with partner CROs regionally and in Europe, Australia, and India. Integrium is privately owned.